Trump administration ends funding for fentanyl test strips, baffling public health groups: “It doesn’t make sense”

The recent decision to stop federal funding for test strips used to detect deadly contaminants in illicit drugs, such as fentanyl, has caused concern among public health organizations. These test strips, costing about $1 each, are crucial in preventing fatal overdoses by checking drugs for harmful additives. The sudden reversal in policy by the Substance Abuse and Mental Health Services Administration (SAMHSA) has left advocates puzzled and scrambling for solutions.

The letter from SAMHSA references an executive order signed by President Trump in July 2025, stating that agency funding cannot support programs that facilitate illegal drug use. However, fentanyl test strips are not considered drug paraphernalia in 45 states and Washington, D.C. SAMHSA had previously supported harm reduction efforts, including the use of test strips, as a way to prevent overdoses. The sudden change in policy has raised concerns about the impact on progress made in combating overdose deaths.

Organizations like the Kentucky Harm Reduction Coalition and Fyrebird Recovery have lost crucial grants due to the funding cut. This has put them in a difficult position as they struggle to continue providing services like distributing test strips. The loss of funding has forced these organizations to seek alternative sources of support, including donations and state funds from opioid crisis settlements.

The sudden budget cuts have raised questions about the future of harm reduction efforts and access to life-saving interventions like naloxone. The decrease in overdose deaths in recent years has been attributed to various factors, including the availability of naloxone and harm reduction strategies like the use of test strips. However, advocates fear that the funding cuts could reverse the progress made and lead to an increase in drug-related harms.

As the United States continues to grapple with the overdose crisis, the decision to cut funding for test strips has sparked concerns about the impact on public health. Advocates emphasize the importance of providing support for harm reduction efforts to prevent overdose deaths and ensure access to life-saving interventions. The future of these initiatives remains uncertain as organizations struggle to find alternative sources of funding in the face of federal budget cuts.